TEHRAN UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1934-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tums.ac.ir
Prophylactic Omentopexy During Laparoscopic Insertion of Peritoneal Dialysis Catheter
Not Applicable
Completed
- Conditions
- Mechanical Complication of Peritoneal Dialysis Catheter
- Interventions
- Other: Prophylactic laparoscopic omentopexy
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT02879734
- Locations
- 🇮🇷
Mohammad Reza Keramati, Tehran, Iran, Islamic Republic of
Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients
Phase 1
- Conditions
- Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]
- Interventions
- Biological: Adipose derived mesenchymal stem cell
- First Posted Date
- 2016-08-04
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT02855112
- Locations
- 🇮🇷
Children's Medical Center, Tehran, Iran, Islamic Republic of
Comparison of Post-operative Complications of Bone Augmentation at Anterior of Maxilla After Periosteal Releasing Incision With Two Techniques Diode Laser and Scalpel
Not Applicable
Completed
- Conditions
- Post-operative Pain
- Interventions
- Procedure: conventional surgery by bladeProcedure: Laser-assisted surgery.
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 14
- Registration Number
- NCT02711501
- Locations
- 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
🇮🇷Neda Moslemi, Tehran, Iran, Islamic Republic of
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
Phase 3
Completed
- Conditions
- Hepatitis CCirrhosis
- Interventions
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT02705534
- Locations
- 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of
Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 32
- Registration Number
- NCT02665806
Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Dietary Supplement: GingerDietary Supplement: placebo
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT02666807
Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema
Phase 2
Completed
- Conditions
- Diabetic Macular Edema
- Interventions
- First Posted Date
- 2016-01-26
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 57
- Registration Number
- NCT02663141
- Locations
- 🇮🇷
Farabi Eye Hospital, Tehran, Iran, Islamic Republic of
A Lifestyle Program on Healthy Weight in Postpartum Period
Not Applicable
Completed
- Conditions
- Weight Reduction
- Interventions
- Behavioral: Lifestyle Intervention
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT02620059
Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2015-11-16
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT02605213
- Locations
- 🇮🇷
Imam khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
Phase 3
Completed
- Conditions
- CirrhosisHepatitis C
- Interventions
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT02596880
- Locations
- 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath